Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alterity Therapeutics Ltd. ( (AU:ATH) ) has provided an announcement.
The Bank of New York Mellon Corporation (BNYMC) has reported a change in its substantial holding in Alterity Therapeutics Ltd., with its voting power decreasing from 33.96% to 24.95%. This shift in voting power could impact BNYMC’s influence over company decisions, potentially affecting Alterity’s strategic direction and stakeholder interests.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on developing therapeutic products aimed at treating neurodegenerative diseases. The company is primarily engaged in research and development activities to address conditions such as Alzheimer’s and Parkinson’s diseases.
Average Trading Volume: 100
Technical Sentiment Signal: Strong Buy
Current Market Cap: $32.01M
For an in-depth examination of ATH stock, go to TipRanks’ Stock Analysis page.